Conference Reports for NATAP

IAS 2025, 13th IAS Conference on HIV Science Kigali, Rwanda July 13-17 Back

Efficacy, safety, and pharmacokinetics of twice-yearly subcutaneous lenacapavir for PrEP among adolescents and young people in the phase 3 trials PURPOSE 1 and PURPOSE 2       ( K. GILL )